Women with irregular heartbeat had higher risk of thinking problems
Women had a higher risk of memory or thinking problems than men, with an adjusted hazard ratio—a relative-risk measure—of 1.14.
Our read
Populations- Studied:
- Preprint: cohort study of 66,885 adults with newly diagnosed atrial fibrillation, median 3.9 years, against men
- What changed:
- Cognitive impairment was higher in women than men: 6.4% against 3.8% at three years
- The catch:
- Outcomes relied on recorded diagnoses in administrative databases
- In the record:
- One of 9 papers on direct acting oral anticoagulants on record: 7 with results in people.
Editor of record: Boris Djordjevic · AgingResearch.News
Alberta’s 66,885 adults aged 40 or older with newly diagnosed atrial fibrillation, an irregular heartbeat, and no heart valve disease formed a retrospective observational cohort. Women made up 43%; their median age was 74, versus 68 for men. Median follow-up was 3.9 years. At three years, cognitive impairment—memory or thinking problems—had developed in 6.4% of women and 3.8% of men.
After accounting for age and other measured differences, women had higher cognitive impairment risk but lower risks of death and vascular dementia, which involves problems with blood supply to the brain. Alzheimer’s disease risk did not differ. Oral blood thinners other than warfarin were linked to lower cognitive impairment risk than warfarin or no blood thinner in both sexes. The range of likely values for women included no difference. Links to lower Alzheimer’s and vascular dementia risk appeared only in men.
Why it matters
For older adults with atrial fibrillation, the work addresses whether sex and blood-thinner use are linked to different risks of cognitive impairment and specific forms of dementia.
Caveats
Outcomes relied on recorded diagnoses, and people prescribed different blood thinners may have differed in health beyond the measured factors. This preprint has not been peer-reviewed; the findings do not cover people with previous cognitive impairment or stroke, or reasons to avoid blood thinners.
- Direct acting oral anticoagulants
- Oral anticoagulants
- Atrial fibrillation
- Mild cognitive impairment
- Vascular dementia
- Humans
The paper
University of Calgary; University of Alberta
medRxiv, Jul 31, 2026, Open access, Preprint, not yet peer-reviewed



Comments
Be the first to comment.